Composition
- Active ingredients
- CARFILZOMIB 30MG/VIAL
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- CARFILZOMIB 30MG/VIAL · PowderThis page
- CARFILZOMIB 10MG/VIAL · PowderNDA202714-003 · Prescription
- CARFILZOMIB 60MG/VIAL · PowderNDA202714-001 · Prescription
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA202714.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Kyprolis
- Active substance
- carfilzomib
- Route
- Intravenous
- Dosage form
- Powder
- Applicant
- Onyx Pharms Amgen
- Status
- Prescription
- FDA approval
- 20 Jul 2012
- Application
- NDA202714-002